If RSV Vaccines Are Approved for Older Adults, What’s Next?

An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings.

Hear answer to questions such as:

• When might potential RSV vaccines be available, and when might the Advisory Committee on Immunization Practices make recommendations on their use?
• How will the vaccine roll out? Who would receive the vaccine first?
• If approved, what will the RSV vaccination schedule be?
• How can we overcome vaccine hesitancy?

Presenters

John J. Russell, MD, FAAFP
Clinical Professor of Family and Community Medicine
Sidney Kimmel College of Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania
Chair, Department of Family and Community Medicine
Abington-Jefferson Health
Abington, Pennsylvania

Laura Hurley, MD, MPH
Associate Professor of Medicine
Division of General Internal Medicine
Department of Medicine
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Primary Care Physician
Division of General Internal Medicine
Department of Medicine
Denver Health
Denver, Colorado

Pamela Rockwell, DO, FAAFP
Professor
Family Medicine
University of Michigan Medical School
Ann Arbor, Michigan

View the full program at:
https://bit.ly/3Wt87GI

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.